HFB-3010

N/A

Report date: 2025/05/29 15:40:01

Base Information

Drug NameHFB-3010
Drug Alias NameHFB-3010HFB-301001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsSolid tumoursUterine NeoplasmsSquamous Cell Carcinoma of Head and Neck +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHiFiBiO Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHiFiBiO Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsUterine NeoplasmsSquamous Cell Carcinoma of Head and NeckCarcinoma, Renal Cell +[6] 

Other Information

ATC CodeN/A
Related LinksN/A